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Abstract The metalation of substituted pyridines, diazines and related
N-heterocycles using TMPMgCl·LiCl, TMP2Mg·2LiCl, TMPZnCl·LiCl or
TMP2Zn·2LiCl2·2MgCl2 (TMP = 2,2,6,6-tetramethylpiperidyl) in the pres-
ence or absence of a Lewis acid is reviewed.
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1 Introduction
The regioselective functionalization of azines, especially
pyridines, is an important synthetic challenge because of
the importance of these N-heterocycles as pharmaceuticals
and agrochemicals.1 The use of lithium bases for achieving
regioselective lithiations has been pioneered by Snieckus,2
Schlosser,3 Quéginer4 and Mongin4h–j,5 as well as Gros.6
These powerful bases produce lithiated N-heterocycles,
which are often only stable at low temperature, although
the performance of such metalations in continuous flow
may avoid such low temperatures.7 Furthermore, the use of
lithium magnesiate or zincate bases pioneered by Mulvey,8
Mongin,8b,9 Uchiyama8b,9b,e,g,l,10 and Kondo8b,10a–c,11 has con-
siderably broadened the scope of metalations for the func-
tionalizations of pyridines and other azines. Recently, it be-
came clear that highly reactive magnesium and zinc bases
can be obtained by mixing sterically hindered magnesium
and zinc bases (derived mostly from 2,2,6,6-tetrameth-
ylpiperidine (TMP-H)) with LiCl.12 The resulting, highly
THF-soluble bases13 are mostly monomeric and kinetically
highly active for the magnesiation and zincation of various
functionalized pyridines or sensitive azines.12 Furthermore,
in such metalations, only magnesiated or zincated hetero-
cycles are produced, which are compatible with a range of
functional groups at moderate to low temperatures. In the
case of the zincation of azines, either ambient or elevated
temperature (up to 120 °C)14 can be used, offering consider-
able potential for industrial applications. Since the metala-
tion of azines using magnesiate or zincate bases has already
been reported extensively,8–11 this review will focus on re-
cent advances describing the most practical and regioselec-
tive C–H activations15 of functionalized pyridines and other
azines, using mostly zinc and magnesium TMP-bases.16
2 Magnesiation of Pyridines and Related 
Azines
2.1 Magnesiations using TMPMgCl·LiCl (1)
Usually, magnesium amides of type R2NMgX or
(R2N)2Mg are aggregated and relatively slow deprotonation
reagents, partially because of their moderate solubility.17
Mulzer pioneered the use of TMPMgCl for the magnesiation
of an azine.18 A base with higher activity and higher solubil-
ity in THF was obtained by using TMPMgCl with LiCl (1
equiv). Thus, mixing of TMP-H with i-PrMgCl·LiCl in THF
(25 °C, 24 h) provides a ca. 1.4 M soluble base TMPMgCl·LiCl
(1).12,13Georg Thieme Verlag  Stuttgart · New York — SynOpen 2018, 2, 78–95
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dines and quinolines under mild conditions. Since magne-
sium reagents are produced, there is no need for low tem-
peratures as it is often the case with corresponding lithia-
tions.19,20 Thus, the magnesiation of 2-bromoquinoline 2
with TMPMgCl·LiCl (1) at –20 °C for 2 h provides the ortho-
magnesiated product 3 (Scheme 1). After bromolysis, the
dibromoquinoline 4 is obtained in 65% yield.21 Pyridines
bearing less sensitive functional groups, such as 3,5-dibro-
mopyridine (5) or 2,6-dichloropyridine (6), are magnesiat-
ed at convenient temperatures (–25 °C or 25 °C), regioselec-
tively providing the pyridylmagnesium derivatives 7 and 8.
Quenching with various electrophiles, such as N,N-dimeth-
ylformamide (DMF) or 4-methoxybenzaldehyde, affords the
polyfunctional pyridines 9 and 10 in 85–92% yield (Scheme
1).12
The last reaction can be readily scaled up to a 100
mmol-scale with no yield loss.22 Aminopyridines are con-
verted into the corresponding trifluoroacetamides such as
11. Deprotonation of the amide function with MeMgCl and
ring-magnesiation with TMPMgCl·LiCl (1) furnishes the
Grignard reagent 12, which, after a transmetalation with
ZnCl2 and Negishi cross-coupling,23,24 affords the 4-arylated
pyridine 13 in 80% yield (Scheme 2).25 The trifluoroacet-
amido group of 11 is an excellent directing group. Similarly,
a sulfoxide function directs a magnesiation in the ortho-
position with high efficiency. Thus, pyridine 14, bearing a
sulfoxide function at position C4, is magnesiated at –30 °C
with TMPMgCl·LiCl (1) within 20 min (Scheme 3). Addition
of ZnCl2 and Negishi cross-coupling with p-iodoanisole cat-
alyzed by 5% Pd(PPh3)4 (50 °C, 2 h) furnishes the tetra-
substituted pyridine 15 in 68% yield. The sulfoxide group
can then be converted into a new magnesium reagent
through sulfoxide–magnesium exchange26 in 2-methyl-
THF27 triggered by i-PrMgCl·LiCl (–50 °C, 5 min). Trans-
metalation with ZnCl2 followed by a Negishi cross-coupling
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Pd(PPh3)4 (50 °C, 5 h), leads to the complex bis-pyridine 17
in 82% yield (Scheme 3).28
Scheme 2  Magnesiation of a trifluoroamidopyridine using 
TMPMgCl·LiCl (1)
Likewise, sulfonamides are excellent directing groups2c–d,29
and can undergo amination reactions when treated with an
excess of a magnesium amide. Thus, sulfonamides 18 and
19 are magnesiated with TMPMgCl·LiCl (1; THF, 0 °C, 2 h).
After iodolysis and amination at 25 °C (2 h) with piperidyl-
magnesium chloride, aminoquinolines 20 and 21 are ob-
tained in 52–59% yield over two steps (Scheme 4).30
TMPMgCl·LiCl (1) also proves to be an excellent base for
the C–H activation of 3-methoxypyridine (22). Thus, treat-
ment of 22 with 10% FeCl3 and 25% diamine (23) and an ex-
cess of TMPMgCl·LiCl (1) at 25 °C for 2 h allows facile alkyla-
tion with various alkyl bromides such as 5-bromopentene
(24), providing the alkylated product 25 in 85% yield
(Scheme 5).31
The N,N,N′,N′-tetramethylphosphordiamidate group
(OP(O)(NMe2)2) was found to be a more powerful directing
group than the methoxy group,32 which allows efficient
magnesiations with TMPMgCl·LiCl (1). Thus, the 4-substi-
tuted pyridine 26 is magnesiated with 1 (1.5 equiv, 0 °C,
1 h) and subsequently thiolated by reaction with MeS-
SO2Me, affording the disubstituted pyridine 27 in 88% yield.
Similarly, quinoline 28 was magnesiated with TMPMg-
Cl·LiCl (1) at 0 °C within 1 h and acylated in the presence of
a copper(I)-catalyst (CuCN·2LiCl), furnishing the ketone 29
in 62% yield (Scheme 6).33 This method has been used to
prepare the pyridine based COX-2 inhibitor etoricoxib 3034
starting from the phosphordiamidate substituted pyridine
31. Thus, the magnesiation of 31 with TMPMgCl·LiCl (1) in
THF at 0 °C for 1 h, followed by a transmetalation with ZnCl2
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Scheme 5  Iron-catalyzed alkylation of 3-methoxypyridine (22)
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provides the arylated pyridine 33 in 88% yield. Standard
transformations and Stille cross-coupling36 provides the de-
sired pharmaceutical 30 (Scheme 7).33
2.2 Magnesiations using TMP2Mg·2LiCl (34) and 
Related Bases
Although TMPMgCl·LiCl (1) is a very powerful magnesi-
ation reagent, in the case of substrates bearing weakly acid-
ic or sterically hindered protons, the magnesiation is advan-
tageously performed using TMP2Mg·2LiCl (34).37 Often, the
presence of sensitive functional groups, such as a carboe-
thoxy group, requires low magnesiation temperatures,
since higher temperatures lead to considerable side reac-
tions. TMP2Mg·2LiCl (34), which is prepared in quantitative
yield by treating TMPLi with 1, can be stored at 25 °C for
several hours. A degradation after several days is however
observed. This base readily magnesiates 4-carbethoxypyri-
dine (35) at –40 °C for 12 h, leading to 36, furnishing, after
iodolysis, the iodopyridine 37 in 66% yield (Scheme 8).37
The phosphordiamidate substituted quinoline 38 was
magnesiated with 34, yielding the magnesium reagent 39
(–50 °C, 1 h). After transmetalation with ZnCl2 and Negishi
cross-coupling using PhI, 5% Pd(dba)2 and 10% P(o-furyl)3 as
catalyst,38 the arylated quinoline 40 is obtained in 81%
yield. Interestingly, the quinoline 40 can now be magnesiat-
ed with TMPMgCl·LiCl (1) at 25 °C within 1 h. The presence
of the phenyl group at position 2 avoids nucleophilic addi-
tions to the quinoline ring and allows higher metalation
temperatures (25 °C instead of –50 °C). Quenching with
NC-CO2Et produces the 2,3,4-trisubstituted quinoline 41,
which is further converted into Talnetant (42), an NK3 re-
ceptor antagonist, in 86% yield (Scheme 8).33
An alternative base with enhanced thermal stability
derived from t-butyl-isopropylamine (tBu(iPr)NH, 43) was
obtained by treating 43 with n-BuLi, giving 44, followed by
the addition of tBu(iPr)NMgCl·LiCl (45), affording the
Scheme 7  Synthesis of Etoricoxib (30) using TMPMgCl·LiCl (1)
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    5% Pd(dba)2




















1) 2 M HCl
    110 °C, 36 h
2) CDI, 50 °C
then S-1-phenyl-
propylamine
70 °C, 5 hGeorg Thieme Verlag  Stuttgart · New York — SynOpen 2018, 2, 78–95
82
M. Balkenhohl, P. Knochel ReviewSyn Openmagnesium bis-amide 46 in >90% yield (Scheme 9).39 The
metalation of 4-t-butoxycarbonylpyridine (47) with 46 pro-
vides the expected pyridine 48 in 68% yield (Scheme 9).39
Scheme 9  Preparation of 46 and magnesiation of 47 with 
[iPr(tBu)N]2Mg·2LiCl (46)
2.3 BF3·OEt2-Promoted Metalations of Pyridines
A typical mono-substituted pyridine, 3-fluoropyridine
(49), can be metalated in two complementary positions
(position C2 or position C4) with TMPMgCl·LiCl (1), either
in the absence or in the presence of the strong Lewis acid
BF3·OEt2 (Scheme 10). Preliminary experiments showed
that BF3·OEt2 does not react in an irreversible manner with
TMPMgCl·LiCl (1) at temperatures below –30 °C. Also, the 3-
fluoro substituent considerably acidifies the adjacent posi-
tions C2 and C4 of 49. The position of the metalation is de-
termined by the nature of the complexation with the TMP-
base.40 Thus, by adding TMPMgCl·LiCl (1) to 49, a complex-
ation of 1 to the heterocyclic N-atom takes place, leading to
a complex of type 50, which favors metalation at position
C2. On the other hand, in the presence of BF3·OEt2, this
strong Lewis acid forms a complex with the N-atom of the
pyridine ring and the base 1 may, if at all, only complex the
fluorine substituent.
This favors a metalation at position C4 (see 51). Thus,
the presence or absence of BF3·OEt2 allows the arylation of
3-fluoropyridine (49) either in position C2 or C4, leading to
the expected products 52 and 53 (Scheme 10).40 The exact
nature of the organometallic species obtained after the
metalation of 49 in the presence of BF3·OEt2 has been exam-
ined by 13C NMR spectroscopy.40,41 This regioselectivity
switch is observed for a range of pyridines. An unexpected
regioselectivity is observed in the case of 2-phenylpyridine
(54). Thus, the treatment of 54 with TMPMgCl·LiCl (1) at
55 °C provides the magnesiated pyridine 55. After iodolysis,
pyridine 56 is obtained in 85% yield. Alternatively, the treat-
ment of 54 with BF3·OEt2, followed by TMPMgCl·LiCl (1),
furnishes, after iodolysis, the 2,6-disubstituted pyridine 57
in 83% yield (Scheme 11).40
Scheme 11  Regioselective metalation of 2-phenylpyridine (54) with or 
without BF3·OEt2
This methodology also allows the functionalization of 4-
dimethylaminopyridine (58) in position 2. In this case, the
coordination with BF3·OEt2 greatly acidifies all the hetero-
cyclic hydrogen atoms, especially those in position C2.
Thus, treatment of 58 with BF3·OEt2 in THF, followed by
TMPMgCl·LiCl (1) at 0 °C for 1 h, furnishes the magnesium
derivative 59 or, after metallotropy, the trifluoroborate de-
rivative 60. After a copper(I)-catalyzed acylation, the 2-
ketopyridine 61 is obtained in 68% yield.42 Similarly, 2-
chloro-4-dimethylaminopyridine (62) is allylated via the
organometallic intermediate 63, furnishing the trisubsti-
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Scheme 10  Regioselective metalation of 3-fluoropyridine 49 in the 
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M. Balkenhohl, P. Knochel ReviewSyn OpenScheme 12  Functionalization of 4-dimethylaminopyridine (58) using 
TMPMgCl·LiCl (1) and BF3·OEt2
Furthermore a regioselective functionalization of (S)-
nicotine (65) via the organometallic intermediate 66, lead-
ing to 6-functionalized nicotine derivatives, such as 67, is
feasible.42 Similarly, the metalation of quinine (68) can be
tuned depending on the reaction conditions used. Thus, the
formation of the lithium alcoholate of quinine followed by
the addition of BF3·OEt2 (2 equiv) is tentatively thought to
provide intermediate 69, which leads to a complexation of 1
at the basic tertiary nitrogen atom and therefore leads to
the 3-iodinated quinoline 70 in 65% yield (Scheme 13).42
By tuning the protecting groups attached to quinine
(68), a switch of the metalation is observed. Thus, the con-
version of 68 into the TBDMS-silyl enol ether 71 followed
by addition of BF3·OEt2 (1 equiv) now leads to the BF3-
adduct 72, which can be metalated with TMPMgCl·LiCl (1)
exclusively at the position C2, providing, after iodolysis, the
2-iodoquinine derivative 73 in 44% yield (Scheme 14).42
Scheme 14  BF3·OEt2-triggered metalation of a silyl-derivative of qui-
nine (71)
The regioselectivity of the metalation of pyridines and
quinolines is the result of steric and electronic factors, often
leading to kinetically controlled products. Thus, the bis-
trimethylsilylmethyl group, which is readily attached to the
pyridine scaffold, directs the metalation by steric effects.
Therefore, the 3-substituted pyridine 74 was activated with
BF3·OEt2 (0 °C, 15 min) and magnesiated with TMP2Mg·2LiCl
(34), since the magnesiation with 1 proved to be ineffective.
The BF3-adduct 75 is exclusively metalated at position C6,
providing, after a Negishi cross-coupling with an iodopy-
rimidine, the bis-azine 76 in 65% yield (Scheme 15).43 Inter-
estingly, 6-bromo-3-bis(trimethylsilylmethyl)pyridine (77)
can be directly metalated by TMP2Mg·2LiCl (34) at 0 °C for
25 h, affording the magnesium derivative 78. Due to the
steric hindrance of the silyl-substituent at position C3, no
magnesiation occurs at position C2, and only a magnesiat-
ion is observed at position C5. Subsequent acylation with
an acid chloride, after transmetalation to copper(I) with
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Scheme 13  BF3·OEt2-triggered metalation of (S)-nicotine (65) and quinine (68) using TMPMgCl·LiCl (1)
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M. Balkenhohl, P. Knochel ReviewSyn OpenScheme 15  Metalation of sterically hindered pyridines bearing a bis-trimethylsilylmethyl substituent
3 Zincation of Pyridines and Related Azines 
using TMPZnCl·LiCl and TMP2Zn·2LiCl·2MgCl2
The availability of kinetically active zinc amides further
extends the scope of directed metalations of functionalized
azines. Two complementary zinc bases TMPZnCl·LiCl (80)
and TMP2Zn·2LiCl·2MgCl2 (81) are obtained from TMPLi
and ZnCl2 or TMPMgCl·LiCl (1) and ZnCl2 (Scheme 16).11,44,45
Since the carbon–zinc bond is much more covalent than the
carbon–magnesium bond, electrophilic functional groups
are much better tolerated in such zinc organometallics and
the directed zincation of various functionalized pyridines
such as 82 and 83 is readily achieved.14 As the carbon–zinc
bond in heteroarylzinc reagents is stable up to 100 °C, di-
rected zincations of pyridines 82–83 have been performed
under microwave irradiation under elevated temperatures
(60–80 °C), providing the corresponding dipyridylzinc re-
agents 84–85 in high yields. After quenching with electro-
philes such as allylic bromides or acyl chlorides in the pres-
ence of a copper(I) catalyst, the expected products 86–87
are obtained in 68–80% yield (Scheme 16).14
Furthermore, pyridylzinc organometallics do not under-
go electron-transfer reactions. Therefore, the electron-defi-
cient nitro group is well tolerated in the zincation of nitro-
substituted pyridines such as 88. In this case, the zincation
proceeds at –40 °C within 1.5 h, leading to the bis-pyridylz-
inc 89. After a copper-catalyzed allylation with 3-bromocy-
clohexene, the trisubstituted pyridine 90 is obtained in 80%
yield (Scheme 17).44 Alternatively, the milder zinc base
TMPZnCl·LiCl (80) can be used to zincate 88 at 25 °C within
5 h and does not require low temperature metalations45,46
leading to the acylated pyridine 91 in 77% yield on 50 mmol
scale (Scheme 17).46
Highly oxidized pyridines, such as pyridine N-oxides,
are smoothly zincated with TMPZnCl·LiCl (80) at 25 °C and
such functionalizations of pyridines are possible in large
scale (20 mmol) in high yields. Scheme 17  Zincation of nitro-substituted pyridine 88 using 
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Scheme 16  Preparation of the TMP-zinc bases TMPZnCl·LiCl (80) and 
TMP2Zn·2LiCl·2MgCl2 (81) and of polyfunctional pyridylzinc reagents 
using 81
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92 with TMPZnCl·LiCl (80), and subsequent cross-coupling
with the heteroaryl bromide 93, provides the desired cross-
coupling product 94 in 95% yield. Remarkably, this reaction
has been extended to diazine N-oxides such as pyridazine
N-oxide 95, providing, after cross-coupling with the hetero-
cyclic bromide 96, the complex heterocycle 97 in 66% yield
(Scheme 18).47
Scheme 18  Metalation of azine N-oxides using TMPZnCl·LiCl (80)
The use of TMPZnCl·LiCl (80) is compatible with electro-
philic aminations as shown by Wang.48,49 Thus, TMPZnCl·LiCl
(80) regioselectively zincates 3-fluoropyridine (49) at 25 °C.
Addition of a Cu(II)-catalyst (5 mol% Cu(OAc)2) at 50 °C for
18 h in the presence of the electrophilic amination reagent,
a benzoyloxypiperazine derivative (98), provides the ami-
nation product 99 in 53% yield at a 60 mmol scale. A related
cobalt(II)-catalyzed amination can be performed under
milder conditions using CoCl2·2LiCl as catalyst (2.5%). In this
case, the amination proceeds at 25 °C. Thus, pyridylzinc
pivalate 100 and 101,50 obtained by the magnesiation of the
corresponding azine and diazine 102 and 103 with TMPMg-
Cl·LiCl (1) followed by the addition of Zn(OPiv)2, are treated
with N-hydroxymorpholine benzoate in THF at 25 °C for 2
h, furnishing the aminated derivatives 104 and 105 in 91–
95% yield (Scheme 19).51
The performance of lateral zincations of pyridines has
been achieved by using TMP2Zn·2LiCl·2MgCl2 (81). Thus,
the treatment of the cyanohydrine derivative 106 with
TMP2Zn·2LiCl·2MgCl2 (81) at 0 °C for 1 h provides the ben-
zylic pyridylzinc derivative 107.
This zinc reagent can be acylated with cyclopropanecar-
bonyl chloride in the presence of 20% CuCN·2LiCl, affording,
after tetrabutylammonium fluoride (TBAF) treatment, ke-
tone 108 in 80% yield (Scheme 20).52
Scheme 20  Lateral zincation of a pyridine cyanohydrine 106 using 
TMP2Zn·2LiCl·2MgCl2 (81)
The scope of azine zincations has been extended by per-
forming a Barbier type zincation in which the metalation is
performed with TMPLi in the presence of ZnCl2·2LiCl at low
temperature. Thus, to a mixture of ZnCl2·2LiCl and the sub-
strate pyridine 109, a THF solution of TMPLi (ca. 1.5 equiv)
is added at –78 °C. Under these conditions, the directed
lithiation of 109 is fast, producing the ortho-lithiated pyri-
dine 110, which is a highly reactive intermediate, that is
transmetalated in situ with the soluble ZnCl2·2LiCl, provid-
ing the stable pyridylzinc reagent 111. Quenching with an
electrophile (E-X) under appropriate reaction conditions


































Scheme 19  Electrophilic aminations of zincated azines using 
TMPZnCl·LiCl (80), TMPMgCl·LiCl (1) and Zn(OPiv)2
N
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M. Balkenhohl, P. Knochel ReviewSyn OpenScheme 21  Barbier type metalation of pyridine 81 using TMPLi in the 
presence of ZnCl2·2LiCl
That such a Barbier reaction proceeds properly relies on
the slow transmetalation between TMPLi and ZnCl2·2LiCl at
–78 °C. On the other hand, the directed lithiation and trans-
metalation steps are required to be fast.53 This reaction set-
up has a good reaction scope and the functionalized pyri-
dines 113–115 are smoothly metalated under these in situ
trapping conditions, using either ZnCl2·2LiCl or MgCl2·2LiCl
as trapping salts, providing the zincated pyridine deriva-
tives 116–118. After quenching with various electrophiles
(aldehydes or aryl halides in the presence of a Pd-catalyst)
the polyfunctionalized pyridines 119–121 are obtained in
79–94% yield (Scheme 22).53
Scheme 22  In situ trapping metalations of polyfunctional pyridines 
113–115
The drawback of these metalations are the required low
reaction temperatures. This problem was overcome by us-
ing a continuous-flow setup (Scheme 23).7a Thus, pyridine
substrates bearing a directing group (DG) are mixed with a
metallic salt (ZnCl2·2LiCl; MgCl2·2LiCl or CuCN·2LiCl), and
added to a TMPLi solution in THF. These solutions were
combined in a commercial flow setup from Uniqsis (1.80
mL/min) at 0 °C for 40 s. This continuous-flow setup has
several advantages, such as enabling a reaction temperature
of 0 °C and a short reaction time of 40 s. Also, the reaction
can be readily scaled-up by pumping the solutions longer
(Scheme 23).7a
Scheme 23  Continuous-flow setup for in situ trapping metalations
By using this procedure, a range of pyridines such as
122–123 are readily functionalized via the intermediate or-
ganometallics 124–125 leading to the expected products
126–127 in 80–98% yield (Scheme 24).7a
Scheme 24  Continuous-flow metalation of pyridines 122–123 using 
TMPLi in the presence of a metallic salt
In some cases, this procedure may be performed by re-
placing TMPLi with the 100 times cheaper lithium bis-
cyclohexylamide (Cy2NLi).54 For example, the ethyl nicoti-
nate 115 was metalated with Cy2NLi (1.5 equiv) at 0 °C
within 40 s and further allylated under copper(I)-catalysis
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M. Balkenhohl, P. Knochel ReviewSyn OpenScheme 25  Continuous-flow metalation of pyridine 115 in the pres-
ence of ZnCl2·2LiCl using Cy2NLi as a cheap lithium amide
The combined use of TMP-zinc and magnesium bases
(TMPMgCl·LiCl (1), TMPZnCl·LiCl (80) and TMP2Zn·2LiCl·
2MgCl2 (81)) in several cases allows a full functionalization
of the pyridine scaffold. Thus, the treatment of 5-bromo-2-
chloropyridine (129) with TMPMgCl·LiCl (1) in THF (–40 °C,
3 h), followed by the addition of tosyl cyanide furnishes the
regioselective product 130 in 68% yield.42 Remarkably, the
pyridine 130 is magnesiated at low temperature with TMP-
MgCl·LiCl (1), affording the 4-magnesiated pyridine 131.
The regioselectivity of this magnesiation may be explained
by a preferential complexation of TMPMgCl·LiCl (1) to the
bromo-substituent, triggering a metalation in position C4.
Quenching with MeSO2SMe provides thioether 132 in 81%
yield. The last metalation is best performed with
TMP2Zn·2LiCl·2MgCl2 (81), leading to the bis-pyridylzinc
133, which was transmetalated to the copper derivative
with CuCN·2LiCl and benzoylated with PhCOCl, leading to
the pentasubstituted pyridine 134 in 61% yield (Scheme
26).42
Scheme 26  Full functionalization of the pyridine scaffold
4 Metalation of Pyridines using other TMP-
Bases
It should be mentioned that related TMP-amide base de-
rivatives from manganese,55 aluminum,56 and lanthanum57
have been reported. Thus, 2-chloro-5-fluoropyridine 135
can be treated with TMP2Mn·4LiCl2 (THF, 0 °C, 4 h), leading
to the bis-pyridylmanganese species 136. After the addition
of chloranil (1 equiv) at –40 °C for 0.5 h, the bis-pyridine
137 is obtained in 64% yield.55c The reaction of the 3-cyano-
pyridine 113 with TMP2Mn·4LiCl (THF, 0 °C, 0.5 h) affords
an intermediate manganese-species 138, which, after trans-
metalation with CuCl·2LiCl, followed by the addition of
LiN(SiMe3)2, leads to 139 and oxidative amination with
chloranil gives the 4-aminopyridine 140 in 75% yield
(Scheme 27).55a
Scheme 27  Magnesiation of pyridine derivatives using TMP2Mn·4LiCl
Aluminum-TMP amides have proven to be especially
useful for the metalation of electron-rich pyridines. Thus,
the treatment of TMPLi with AlCl3 provides the correspond-
ing TMP3Al·3LiCl base (141) as a 0.3 M solution in THF. This
base readily aluminates the 2-methoxypyridine 142 leading
to the tris-arylaluminum 143, which provides, after trans-
metalation to zinc and to copper, and acylation, the expect-
ed ketone 144 in 90% yield (Scheme 28).56
The treatment of TMPMgCl·LiCl with LaCl3·2LiCl58,59 and
its addition to a functionalized pyridine such as 115 leads
to an organometallic intermediate best represented as 145.
From recent results,59 the reagent 145 may be better repre-
sented as a magnesium reagent complexed with LaCl3, rath-
er than a true aryllanthanum species.59 However, the reac-
tion of 145 with the sterically hindered ketone 146 leads to
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M. Balkenhohl, P. Knochel ReviewSyn OpenScheme 29  Metalation of the functionalized pyridine 115 using 
TMPMgCl·LaCl3·nLiCl
5 Magnesiation and Zincation of Diazines
Whereas the metalation of pyridines and quinolones is
relatively well explored, the metalation of diazines such as
pyrimidine (148), pyrazine (149), and pyridazine (150) is
much less studied, and the functionalization of these N-het-
erocycles remains a challenge, as the predictability of the
appropriate base for their metalation is still difficult (Figure
1).
Figure 1  Diazine scaffolds
Nevertheless, the TMP-bases TMPMgCl·LiCl (1),
TMP2Mg·2LiCl (34), TMPZnCl·LiCl (80) and TMP2Zn·2Li-
Cl·2MgCl2 (81) have proven to be a set of very useful meta-
lation reagents, especially well-suited for the functionaliza-
tion of diazines and annulated analogues. These bases also
constitute an automated strong base screening platform, as
recently shown by Boga and Christensen.60 Some recent ap-
plications are shown below, as well as guidelines for ratio-
nalizing the metalations of various diazines. Whereas py-
rimidine itself has a high propensity to add magnesium nu-
cleophiles, substituted pyrimidines are better substrates for
metalations. Thus, 2-bromopyrimidine (151) undergoes a
smooth magnesiation with TMPMgCl·LiCl (1) at –55 °C
within 1.5 h and produces the 4-magnesiated pyrimidine
152 in >90% yield. After thiolation of 152 with MeSO2SMe,
the corresponding thioether 153 is obtained in 81%
yield.61,62 The methylthio substituent has a highly stabiliz-
ing effect and considerably stabilizes the pyrimidine to-
wards unwanted nucleophilic additions. Thus, further mag-
nesiation of 153 may now be performed at room tempera-
ture and the metalation is complete within 5 min,
producing the magnesiated pyrimidine 154, which, after
chlorination, provides the trisubstituted pyrimidine 155 in
76% yield. The last position of the ring is magnesiated under
similar conditions furnishing, after copper(I)-mediated
benzoylation, the ketone 156 in 81% yield (Scheme 30).61
Scheme 30  Regioselective magnesiations of 2-bromopyrimidine (151) 
using TMPMgCl·LiCl (1)
This methodology has been applied to the functional-
ization of 2-chloropyrimidine (157), providing a convenient
synthesis of the fungicide mepanipyrim 158.63 Thus, the
magnesiation of 157 at –60 °C is complete within 2 h using
TMPMgCl·LiCl (1). Transmetalation with ZnCl2 and iodolysis
affords the bis-halogenated pyrimidine 159 in 91% yield.
Subsequent magnesiation with TMPMgCl·LiCl (1; –60 °C,
1 h) followed by a bromination with 1,2-dibromotetrachlo-
roethane affords the tri-halogenated pyrimidine 160 in al-
most quantitative yield (96%). Negishi cross-coupling of the
most reactive iodine-substituent at 160 using MeZnBr fur-
nishes the pyrimidine 161 in 58% yield. Sonogashira cross-
coupling with propyne gives the alkynylpyrimidine 162 in
97% yield. Finally, Pd-catalyzed amination of 162 with ani-
line furnishes mepanipyrim 158 in 81% yield (Scheme 31).63
The amination of the pyrimidine scaffold can also be
achieved using TMPMgCl·LiCl (1). Thus, the magnesiation of
dichloropyrimidine 163 with 1 at 25 °C for 0.5 h produces
the magnesium reagent 164. Its transmetalation with
CuCl·2LiCl followed by the addition of N-lithiomorpholine
(165) leads to the lithium amidocuprate 166, which, after
oxidative amination using chloranil, leads to the 5-amino-
pyrimidine 167 in 68% yield (Scheme 32).63,64
The regioselectivity of the metalation of uracil may be
controlled by the bases used.65–67 Thus, the deprotonation
of 2,4-dimethoxypyrimidine 168 with TMPLi proceeds
through precomplexation of the lithium base at oxygen and
leads to an ortho-lithiation (169). On the other hand, mag-
nesiation with TMPMgCl·LiCl (1) in THF is triggered by a
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M. Balkenhohl, P. Knochel ReviewSyn Opencomplexation of the magnesium base 1 at the heterocyclic
N-atom and therefore leads to a magnesiation at the ortho-
position to nitrogen, providing the magnesium derivative
170.57 After quenching with ethyl cyanoformate, the uracil
171 is obtained in 71% yield. Subsequent magnesiation
leads to 172 and a copper(I)-mediated benzoylation gives
ketone 173 in 78% yield (Scheme 33).67,68
Scheme 31  Synthesis of the fungicide mepanipyrim 158 starting from 
2-chloropyrimidine (157) using TMPMgCl·LiCl (1)
Scheme 32  Amination of the pyrimidine scaffold using TMPMgCl·LiCl 
(1)
The magnesiation of dichloropyrimidine 163 (25 °C,
0.5 h) with TMPMgCl·LiCl (1) provides the magnesium de-
rivative 164 as shown in Scheme 32. Its treatment with chi-
ral sulfamidate 174 for 1 h at 25 °C followed by acidification
with trifluoroacetic acid (TFA) and heating with Et3N (4
equiv) in MeCN for 0.5 h at 80 °C leads to the chiral hetero-
cycle 175 in 85% yield. Using the sulfamidate 176 provides
tetrahydropyridopyrimidine 177, which is a precursor for
various unsaturated heterocycles (Scheme 34).69
Scheme 34  Preparation of annulated pyrimidine 175 and 177
The use of magnesium intermediates in some cases
leads to rearrangements,70,71 as shown by the magnesiation
of indolizine 178 using TMPMgCl·LiCl (1) at 25 °C for 1 h.
Under these conditions, a dynamic equilibrium between
the two isomeric magnesium species 179 and 180 is ob-
served. Whereas more reactive electrophiles such as iodine
and aldehydes provide the products of type 181, less reac-
tive electrophiles such as Cl3CCCl3 or a Negishi cross-
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M. Balkenhohl, P. Knochel ReviewSyn OpenScheme 35  Electrophile controlled regioselectivity in the functional-
ization of indolizine 178 using TMPMgCl·LiCl (1)
An in situ trapping procedure in several cases avoids
side-reactions and provides high yields of products. Thus,
the functionalization of the quinoxaline scaffold is possible
using TMPLi. The treatment of dichloroquinoxaline 183
with TMPLi (2.4 equiv) in the presence of an excess of TMS-
Cl furnishes the bis-silyl derivative 184 in 74% yield. After
the addition of ICl (1 equiv) the mono-iodinated quinoxal-
ine derivative 185 is obtained in 63% yield.72 Similarly, the
2,7-naphthyridine 186 can be converted into silyl derivative
187 in 73% yield (Scheme 36).73
Scheme 36  Functionalization of quinoxalines and 2,7-naphthyridines 
using TMPLi
The 1,5-naphthyridine scaffold (188) has been exam-
ined in more detail. Complexation of TMP2Mg·2LiCl (34) to
the nitrogen-atom N1 of 188 leads to a selective metalation
in position C8. This magnesiation has to be performed at –
78 °C (for 5 min) to avoid decomposition of the metalated
species. The resulting magnesium species 189 can be func-
tionalized with various electrophiles E1-X providing prod-
ucts of type 190. The mono-substituted naphthyridines 190
can be regioselectively functionalized using either TMPMg-
Cl·LiCl (1) or the combination of 1 and BF3·OEt2. In the first
case, complexation of the base 1 occurs at the sterically
most accessible N5, leading to a magnesiation and thus
functionalization at position C4 (191).
On the other hand, the addition of BF3·OEt2 prior to the
addition of 1 blocks a complexation of the magnesium base
at N5 and, since N1 is also inaccessible due to the substitu-
ent E1, leads to a complexation of 1 to the BF3 unit and a
deprotonation of the most acidic hydrogen at position C6.
After quenching with an electrophile E2-X the disubstituted
1,5-naphthyridine 192 is obtained (Scheme 37).74 The
products of type 192 may be further metalated, although a
very strong lithium base (TMPLi) is required. Thus, the reac-
tion of 192a with TMPLi at –78 °C for 0.5 h provides the
lithium intermediate 193, which is trapped with iodine,
furnishing the adduct 194 in 70% yield. The use of TMPLi
also allows a fourth functionalization and the reaction of
194 with TMPLi at –78 °C for 90 s (!) leads to an ortho-lithi-
ation, providing the lithium reagent 195, which gives the
more stable lithium derivative 196 through an intramolecu-
lar iodine–lithium exchange. After quenching with an elec-
trophile such as an acid chloride in the presence of stoichio-
metric amounts of CuCN·2LiCl, the corresponding ketone
197 is obtained in 70% yield (Scheme 38).74 This methodol-
ogy can be applied for the synthesis of an antibacterial
agent such as 198. Thus, the magnesiation of 1,5-naphthyri-
dine 188 with TMP2Mg·2LiCl (34) from –40 to –20 °C for
4 h, followed by a transmetalation with ZnCl2 and Pd(0)-
catalyzed cross-coupling with 4-tert-butylphenyl iodide,
provides the arylated naphthyridine 199 in 88% yield.
TMPLi-lithiation at position C4 followed by a methylation
with methyl triflate affords the disubstituted naphthyridine
200 in 53% yield. This naphthyridine can be converted into
the antibacterial drug candidate 198 (Scheme 39).74,75
Scheme 37  Regioselective magnesiation and functionalization of 
1,5-naphthyridines using TMP2Mg·2LiCl (34) and TMPMgCl·LiCl (1) in 
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M. Balkenhohl, P. Knochel ReviewSyn OpenScheme 38  Tri- and tetra-functionalization of 1,5-naphthyridines us-
ing TMPLi
TMPMgCl·LiCl (1) can be used to magnesiate highly
functionalized 2,7-naphthyridines such as 201. Thus, the
treatment of 201 triggered by a coordination at N2, affords
the magnesium derivative 202, which undergoes an intra-
molecular addition to the carbethoxy function, providing
the alkaloid sampangine 203 in 35% yield (Scheme 40).76
Bracher has extended this strategy to a marine pyrido-
acridine alkaloid demethyldeoxyamphimedine (204). Thus,
the magnesiation of ethyl nicotinate 205 with TMPMgCl·Li-
Cl (1) in the presence of BF3·OEt2, followed by transmetala-
tion with ZnCl2, furnishes the zinc reagent 206, which, after
cross-coupling with 2-iodoaniline in the presence of a pal-
ladium-catalyst, furnishes the lactam 207 in 50% yield. Con-
version into the corresponding bromide 208 using POBr3,
followed by a second cross-coupling with the zincated ethyl
nicotinate 206, produces the naphthyridine 209 in 78%
yield. Cyclization of 209 with TMPMgCl·LiCl (1) furnishes
the desired marine pyridoacridine alkaloid 204 in 28% yield
(Scheme 41).77
The metalation of the cinnoline scaffold (210) can also
be realized using TMP2Mg·2LiCl (34). Thus, the reaction of
210 first with BF3·OEt2, followed by the addition of
TMP2Mg·2LiCl (34) at –78 °C for 10 min, leads to a regio-
selective magnesiation at C3. This regioselectivity can be
explained by assuming that BF3·OEt2 complexes at the most
readily available nitrogen N2 and that TMP2Mg·2LiCl coor-
dinates at BF3 leading to a metalation at C3 (see 211). After
Pd(0)-catalyzed cross-couplings, the desired arylated prod-
ucts of type 212 are obtained. Alternatively, the metalation
of 210 with TMP2Zn·2LiCl·2MgCl2 (49) in the presence of
MgCl2 leads to a preferential complexation at N1 of the base
and at N2 of MgCl2, favoring a zincation at C8 via a transi-
tion state of type 213. After palladium-catalyzed arylation
with various aryl iodides, 8-arylated cinnolines of type 214










































































Scheme 40  TMPMgCl·LiCl (1) magnesiation of the 2,7-naphthyridine 




















Scheme 41  Preparation of the alkaloid demethyldeoxyamphimedine 
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M. Balkenhohl, P. Knochel ReviewSyn OpenScheme 42  Regioselective metalation of the cinnoline scaffold using 
TMP2Mg·2LiCl (34) and TMP2Zn·2LiCl·2MgCl2 (81)
As shown above, the presence or absence of a Lewis acid
such as BF3·OEt2 or MgCl2 is essential for achieving a high
regioselectivity in metalations with TMP-bases. This has
been demonstrated for various heterocyclic metalations.79–
81 Especially relevant in the frame of this review is the regi-
oselective metalation of the pyrazine scaffold. Thus, the in-
troduction of a bulky bis-trimethylsilylmethyl-substituent
to the pyrazine core is readily realized by treating chloropy-
razine 215 with the magnesium reagent 216. The resulting
silyl-substituted pyrazine 217 proved to be difficult to mag-
nesiate using TMP-magnesium bases such as 1 or 34. How-
ever, a precomplexation with BF3·OEt2 sufficiently acidifies
the ring hydrogen atoms, allowing a regioselective metala-
tion at the least sterically hindered position at C5 (see 218,
Scheme 43).81
The resulting magnesium reagent 219 reacts with vari-
ous electrophiles. Chlorination with PhSO2Cl provides the
chloropyrazine 220 in 61% yield. This pyrazine is readily
magnesiated in a subsequent step. Remarkably, the induc-
tive effect of the chlorine substituent is sufficient for a mag-
nesiation to be achieved with TMP2Mg·2LiCl (34) in the ab-
sence of BF3·OEt2. The resulting magnesiated pyrazine 221
can be brominated with 1,2-dibromotetrachloroethane
providing the bis-halogenated pyrazine 222 in 93% yield. Fi-
nally, the last ring hydrogen of 222 can again be metalated
with TMP2Mg·2LiCl (34), leading to the magnesium species
223, which, after iodolysis, provides the tri-halogenated
pyrazine 224 in 83% yield (Scheme 44).81
The metalation of the pyrazine and the pyridazine scaf-
folds remains a challenge and usually quite strong bases are
required for these metalations. Especially for the pyridazine
scaffold, either yields are low or the electrophile scope is
narrow.8f,9a The presence of two chlorine substituents in
3,6-dichloropyrazine 225 facilitates the metalation and
now TMP2Zn·2LiCl·2MgCl2 (81) leads to a zincation at
–78 °C.82 Also, a more convenient zincation of pyridazine
225 can be realized at 25 °C with TMPZnCl·LiCl (80). The re-
sulting zinc reagent 226 can be acylated after a transmeta-
lation with CuCN·2LiCl, leading to the corresponding ketone
227 (Scheme 45).45 Similarly, the corresponding dibro-
mopyridazine 228 is zincated with TMPZnCl·LiCl (80) under
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M. Balkenhohl, P. Knochel ReviewSyn Open229, which is benzoated, after transmetalation with
CuCN·2LiCl, leading to the ketone 230 in 86% yield (Scheme
45).46,83
Scheme 45  Zincations of the halogenopyridazines 225 and 228
Finally, zinc-TMP-bases are especially efficient for the
zincation of 2-pyridones and 2,7-naphthyridones. Thus,
treatment of functionalized 2-pyridone 231 with
TMP2Zn·2LiCl (81) at –10 °C for 72 h leads to the zincated
pyridone 232, which, after iodolysis, affords the iodopyri-
done 233 in 80% yield. Similarly, naphthyridone 234 is zin-
cated regioselectively and Pd-catalyzed cross-coupling with
4-iodoaniline provides the cross-coupling product 235 in
76% yield (Scheme 46).84
Scheme 46  Functionalization of 2-pyridones and 2-naphthyridones us-
ing TMP2Zn·2LiCl·2MgCl2 (81)
6 Conclusion
The functionalization of azines and diazines is an im-
portant task for pharmaceutical and agro-chemical re-
search. Herein, we have summarized recent developments
in the field of azine metalation using TMPMgCl·LiCl (1),
TMP2Mg·2LiCl (34), TMPZnCl·LiCl (80), and TMP2Zn·2Li-
Cl·2MgCl2 (81), and have shown that they are excellent bas-
es for the functionalization of N-heterocycles. The addition-
al use of BF3·OEt2 or MgCl2 as Lewis acids considerably ex-
pands the scope of these bases. Furthermore, the
performance of such metalations not in batch, but in con-
tinuous flow, allows further tuning of the reaction condi-
tions, so that more convenient reaction temperatures and
short reaction times can be achieved. In the future, the
combination of these methods will certainly facilitate the
functionalization of diazines and benzo-analogues further,
since this research is still in its infancy.
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